Cite
HARVARD Citation
Guo, B. et al. (2023). A Bayesian phase I/II design to determine subgroup‐specific optimal dose for immunotherapy sequentially combined with radiotherapy. Pharmaceutical statistics. pp. 143-161. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Guo, B. et al. (2023). A Bayesian phase I/II design to determine subgroup‐specific optimal dose for immunotherapy sequentially combined with radiotherapy. Pharmaceutical statistics. pp. 143-161. [Online].